Tandem Diabetes Care (TNDM) Has Climbed To A New High For The Year
Tandem Diabetes Care (TNDM) has been rising since the open of trade Wednesday and is now up 1.13 at $18.83.
Source: RTTNews
FDA Approves Aurinia Pharmaceuticals' (Nasdaq: AUPH / TSX: AUP) LUPKYNIS (voclosporin) for Adult Patients with Active Lupus Nephritis




